To determine the role of PGE2 in tumour escape from anticancer T cell responses, we generated Cd4crePtger2−/−Ptger4fl/fl mice in which Cre recombinase activity induces the deletion of EP4 in CD4+ and CD8+ T cells on a global EP2-deficient background. The gene discussed is CD8A; the disease is neoplasm.